Research programme: RNA targeted therapeutics - ProQR Therapeutics
Latest Information Update: 25 Apr 2023
Price :
$50 *
At a glance
- Originator ProQR Therapeutics
- Class Oligonucleotides
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified